Intracoronary eptifibatide with vasodilators to prevent no-reflow in diabetic STEMI with high thrombus burden. A randomized trial

Authors
Category Primary study
JournalREVISTA ESPANOLA DE CARDIOLOGIA
Year 2022
This article has no abstract
Epistemonikos ID: e3f296c059476ec56f54a4d4db7db63a7e5abc31
First added on: Nov 22, 2025